The Role of Aldosterone Blockade in End-Stage Renal Disease

Publisher： Karger

E-ISSN： 1421-9751|114|1|30-31

ISSN： 0008-6312

Source： Cardiology, Vol.114, Iss.1, 2009-04, pp. : 30-31

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Aldosterone, mortality, cardiovascular events and reverse epidemiology in end stage renal disease

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 45, Iss. 10, 2015-10 ,pp. : 1077-1086

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aldosterone, mortality, cardiovascular events and reverse epidemiology in end stage renal disease

By  

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (ELECTRONIC), Vol. 14-2972, Iss. 10, 2015-10 ,pp. : 1077-1086

John Wiley & Sons Inc

Access to resources Recommend Favorite

QT–interval parameters in end–stage renal disease

By Cardoso C.   Salles G.  

Clinical Autonomic Research, Vol. 14, Iss. 4, 2004-08 ,pp. : 214-216

Springer Publishing Company

Access to resources Recommend Favorite

Optimising Treatment of End-Stage Renal Disease in the Elderly

By  

Nephron Clin Pract, Vol. 124, Iss. 3-4, 2014-01 ,pp. : 202-208

Karger

Access to resources Recommend Favorite

Psychotherapeutic Agents in End‐Stage Renal Disease

By  

SEMINARS IN DIALYSIS, Vol. 28, Iss. 4, 2015-07 ,pp. : 417-426

John Wiley & Sons Inc

Access to resources Recommend Favorite